Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1992-3-10
|
pubmed:abstractText |
The antitumor activity of mouse polymorphonuclear leukocyte (PMN) treated with a beta-1,3-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 (TAK-N) and its carboxymethylated derivative (CM-TAK) was investigated in vitro and in vivo. ICR mouse PMN showed strong cytotoxicity against sarcoma 180 cells and inhibition of the growth of the tumor cells in vitro in the presence of TAK-N but not in the presence of CM-TAK. Since the cytotoxicity induced by TAK-N was almost completely inhibited by catalase, it seems to be mediated by H2O2 production by PMN. On the other hand, TAK-N induced no cytotoxicity in macrophages and neither did CM-TAK in PMN or in macrophage. Intraperitoneal injection of TAK-N into ICR mice induced a large number of PMN and macrophages in the peritoneal cavity. The peritoneal exudate PMN which were harvested at 10 to 72 h after TAK-N injection showed cytotoxicity against sarcoma 180 cells, but the peritoneal exudate macrophages did not. Treatment of sarcoma 180 ascites tumor-bearing ICR mice with TAK-N at a dose of 100 mg/kg prolonged significantly the survival time over that of the control. These results indicate that TAK-N induces PMN cytotoxicity against sarcoma 180 cells not only in vitro but also in vivo. The antitumor effect of TAK-N on sarcoma 180 ascites tumor seems to be derived from PMN stimulated with TAK-N.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0386-846X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
519-25
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1779406-Animals,
pubmed-meshheading:1779406-Cytotoxicity, Immunologic,
pubmed-meshheading:1779406-Free Radical Scavengers,
pubmed-meshheading:1779406-Glucans,
pubmed-meshheading:1779406-Macrophages,
pubmed-meshheading:1779406-Mice,
pubmed-meshheading:1779406-Mice, Inbred ICR,
pubmed-meshheading:1779406-Neoplasms, Experimental,
pubmed-meshheading:1779406-Neutrophils,
pubmed-meshheading:1779406-Sarcoma 180,
pubmed-meshheading:1779406-beta-Glucans
|
pubmed:year |
1991
|
pubmed:articleTitle |
Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
|
pubmed:affiliation |
Chemotherapy Division, Chiba Cancer Center Research Institute, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|